According to a time-honoured dogma, adult brain cells are incapable of division and thus any kind of severe brain damage will be irreparable. This assumption is increasingly questioned, on the basis of studies showing regeneration of various cell types in the adult central nervous system (CNS)1. Moreover, cells isolated from the hippocampus or other encephalic regions have proved capable not only of self-renewal but also of differentiation into neurons, astrocytes and oligodendrocytes (which are responsible for the formation of myelin sheaths around axons)-thus behaving like classic stem cells2. These observations open the way, in theory, to several different strategies for replacing damaged neural tissue (see Figure 1 ). The first is the reactivation of local neural stem cells still present in the adult CNS. The second is transplantation into the brain of early but differentiated neural cells that survive in culture. And a third, more daring, is stimulation of human embryonic stem cells, surviving as immortalized cell lines, to differentiate into neural cells and implantation of such cells into the damaged nervous tissue. This last approach is based on experimental evidence that neural precursors derived from embryonic cells, when incorporated into encephalic regions, can assume features identical to those of the host cells. Behind the vast research effort now underway is the hope of beneficially modifying the course of Alzheimer's disease, Parkinson's disease and other severe disorders of the CNS. In this review I examine the background to these techniques and the difficulties that arise in their application.
EVIDENCE FOR A NEURAL STEM CELL
The first reports of postnatal neurogenesis date back to the 1 960s, when evidence of such regeneration was found in rat and guineapig hippocampus3. Further experiments pointed to other regions, such as the forebrain ventricular wall, that might be harbouring neural stem cells. However, in the wall of the subventricular zone and facing the lumen is a layer of rapidly proliferating ependymal cells4, and discussion now centres on whether these are the real stem cells or simply represent a compartment of progenitor cells in transit. There is some controversy about the potential of these adult subependymal cells: some workers deny that they are capable of multilineage transformation; others, on the basis of experiments both in vitro and in vivo, affirm their potential for reconstituting the complete population following depletion5.
An additional question has been raised: might there be not one type but various subsets of stem cells, capable of specific differentiation, with alternative pathways responding to different growth factors? At present, evidence favours a single type. Undifferentiated cells from the subventricular zone of adult mammalian forebrain, when exposed to either epidermal growth factor (EGF) or fibroblast growth factor 2 (FGF2), proliferated and were immortalized in culture; and EGF-responsive cells can yield progeny that when exposed in vitro to FGF2 gives rise to neurons and glia6. As for regeneration from white matter, since the early 1990s there have been numerous reports on the use of human neuroblasts to promote growth of long axons in the CNS of adult laboratory animals. It is now clear that adult axons are capable of extending rapidly and for long distances into white matter, and eventually into grey matter7; in other words, the possibility of regenerative growth from such adult neurons has also been established.
EMBRYONIC AND ADULT CELL LINES
Stem cell lines from the inner mass of mouse embryos have been successfully established since the early 1980s. Such embryonic stem cells can be maintained in culture in a primitive undifferentiated state, and in theory they might give rise to almost every cell type in the body. Stimulation with FGF4, for example, causes differentiation in vitro into various subtypes8.
Parallel efforts with human cells have been underway, and culminated last year with an announcement that immortal cell lines had been established from human embryonic stem cells9'10. Such cell lines show a high level of telomerase-an enzyme associated with longevity in culturell. Their when they were injected into immunodeficient mice; the resultant lesions comprised tissues of multiple origin, including neural epithelium. Cell lines can also be obtained from adult brain tissue, particularly the hippocampus region. In the presence of appropriate stimulants they have survived and proliferated for long periods (years), and have generated mature neurons when grafted into adult rat brain12.
All these cell lines offer research possibilities. An obvious one, in the case of embryonic cells, is study of human embryo development, including the reasons why it can go wrong; and another is in drug screening, perhaps reducing the need for animal testing. But from our point of view the most promising is the production of differentiated cells and tissues for transplantation into various organs13.
The versatility of stem cells under the influence of modifying factors is already well known. A stunning recent example is the transformation of labelled neural progenitors into various blood cell types (lymphoid and myeloid cells as well as red cell precursors14). Another is the differentiation of mesenchymal cells from human bone marrow into differentiated cells including adipocytes, chondrocytes and osteocytes according to culture conditions15.
ONCOGENIC POTENTIAL OF STEM CELL LINES I have stressed the importance of a high telomerase activity in preserving or promoting the survival of both embryo and adult stem cell lines. This raises a big caveat concerning therapeutic applications: might cells thus immortalized change their character with time, developing neoplastic features, particularly when introduced into the body. A reassuring observation is that telomerase-treated cells maintain their diploid state, their growth pattern and the gene expression of young normal cells16. Moreover, such cells seem unable to produce tumour-like colonies when grown in soft agar cultures and no tumours have been seen after transplantation into susceptible mice. Nonetheless, there are persistent worries about late neoplastic transformation, because normal senescence is generally perceived as one of the cell's safeguards against cancer, creating a barrier to any cell escaping its normal growth control17. More experiments are needed to rule out this possibility.
TRANSPLANTATION ATTEMPTS
There is now experimental evidence that repopulation of substantial areas of the brain can be accomplished by cell transplants: in laboratory animals a widely used model is the lesioned striatum, into which are inserted cells or tissues of varying maturity18. The method has also been successfully tried in patients with Parkinson's disease: implantation of early dopamine-producing cells restored neurotransmission interesting dilemma: will the best results be obtained with undifferentiated cells and tissues or with cells in which the desired maturation has already taken place? If the former, differentiation will result from the action of stimulating factors operating within the host; and, as mentioned earlier, such site-specific differentiation has already been demonstrated. However, there is an argument for initiating, or even fully promoting, differentiation within the stem cell population to be engrafted. This strategy, involving use of several stimulating factors, has been successfully applied by several groups of investigators, and the general view is that neural precursors generated by controlled differentiation of primitive undifferentiated cells can respond to environmental signals determining differentiation and migration in such a way that, when implanted in different regions, they can constitute the entire cell population of the nervous tissue20.
Very recent experiments also show that primary neural cells can form colonies in response to growth factors and are capable not only of self-renewal but also of generating all three major neural cell lineages neurons, astrocytes and oligodendrocytes. Moreover, the experiments confirmed that EGF-responsive and FGF2-responsive stem-celllike cells derive from a single progenitor, able to respond to both growth factors21. PROSPECTS Does this background offer hope that repair for critical neurodegenerative disorders will be possible in the near future? The difficulties are daunting but the potential applications are very extensive. In CNS disorders such as Parkinson's disease or Alzheimer's disease it has been postulated that the primary insult causing neuron loss is aggravated by lack of regeneration: if this could be corrected, the impact of the disease could be greatly alleviated.
So how might this be done? First we should consider ways to activate or reactivate local neurogenesis; this could be achieved mainly by the action of specific stimulating factors. Since the normal rate of neurogenesis is slow, at least as calculated in laboratory animals, enhancement could be provided by an enriched environment i.e. by transplantation of neural cells22. These could be either adult differentiated cells or stem cells in which neural differentiation had been initiated previously. An encouraging recent observation is that proliferation of human stem cell progeny in the striatum of immunodeficient mice was detectable 1 year after grafting23.
More experimental data are required on the mechanism of neural tissue regeneration but existing evidence offers hope that useful treatments will emerge. CNS repair is not in the affected area19. We are therefore confronted with an 503 just around the corner, but it is a credible goal.
